Atmospheric freeze drying for the reduction of powder electrostatics of amorphous, low density, high surface area pharmaceutical powders

Drug Development and Industrial Pharmacy

Volumn 39, Issue 2, 2013, Pages 205-217

  O'Donnell, K P ^a   Cai, Z ^a   Schmerler, P ^a   Williams III, R O ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Atmospheric freeze drying; Chargeability; Electrostatic; High specific surface area; Lyophilization

Indexed keywords

DIOXANE; ITRACONAZOLE;

ARTICLE; ATMOSPHERIC FREEZE DRYING; ATMOSPHERIC PRESSURE; DIFFERENTIAL SCANNING CALORIMETRY; FILM; FREEZE DRYING; MEASUREMENT; PARAMETERS; POWDER; SCANNING ELECTRON MICROSCOPY; STATIC ELECTRICITY; TEMPERATURE; THIN FILM FREEZING; X RAY DIFFRACTION;

ANTIFUNGAL AGENTS; DESICCATION; FREEZE DRYING; ITRACONAZOLE; PARTICLE SIZE; POWDERS; STATIC ELECTRICITY;

EID: 84872449575     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2012.669385     Document Type: Article

References (56)

1. Amidon GL, Lennernäs H, Shah VP, Crison JR. (1995). A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res, 12:413-420.
2. Hauss DJ. (2007). Oral Lipid-Based Formulations: Enhancing the Bioavailability of Poorly Water Soluble Drugs. New York: Informa Healthcare.
3. Merisko-Liversidge E, Liversidge GG, Cooper ER. (2003). Nanosizing: a formulation approach for poorly-water-soluble compounds. Eur J Pharm Sci, 18:113-120. (Pubitemid 36184748)
4. Serajuddin AT. (2007). Salt formation to improve drug solubility. Adv Drug Deliv Rev, 59:603-616. (Pubitemid 47285406)
5. Wang Y, Jiang ZT, Li R. (2009). Complexation and molecular microcapsules of Litsea cubeba essential oil with β-cyclodextrin and its derivatives. European Food Research and Technology 228: 865-873.
6. Dellamary LA, Tarara TE, Smith DJ, Woelk CH, Adractas A, Costello ML et al. (2000). Hollow porous particles in metered dose inhalers. Pharm Res, 17:168-174. (Pubitemid 30158365)
7. Hirst PH, Pitcairn GR, Weers JG, Tarara TE, Clark AR, Dellamary LA et al. (2002). In vivo lung deposition of hollow porous particles from a pressurized metered dose inhaler. Pharm Res, 19: 258-264. (Pubitemid 34211841)
8. Engstrom JD, Simpson DT, Lai ES, Williams RO 3rd, Johnston KP. (2007). Morphology of protein particles produced by spray freezing of concentrated solutions. Eur J Pharm Biopharm, 65:149-162. (Pubitemid 46038083)
9. Overhoff KA, Engstrom JD, Chen B, Scherzer BD, Milner TE, Johnston KP et al. (2007). Novel ultra-rapid freezing particle engineering process for enhancement of dissolution rates of poorly water-soluble drugs. Eur J Pharm Biopharm, 65:57-67. (Pubitemid 44827696)
10. Friesen DT, Shanker R, Crew M, Smithey DT, Curatolo WJ, Nightingale JA. (2008). Hydroxypropyl methylcellulose acetate succinate-based spray-dried dispersions: an overview. Mol Pharm, 5:1003-1019.
11. McConville JT, Overhoff KA, Sinswat P, Vaughn JM, Frei BL, Burgess DS et al. (2006). Targeted high lung concentrations of itraconazole using nebulized dispersions in a murine model. Pharm Res, 23:901-911. (Pubitemid 43781398)
12. Overhoff KA, Moreno A, Miller DA, Johnston KP, Williams RO 3rd. (2007). Solid dispersions of itraconazole and enteric polymers made by ultra-rapid freezing. Int J Pharm, 336:122-132. (Pubitemid 46551563)
13. Overhoff KA, McConville JT, Yang W, Johnston KP, Peters JI, Williams RO 3rd. (2008). Effect of stabilizer on the maximum degree and extent of supersaturation and oral absorption of tacrolimus made by ultra-rapid freezing. Pharm Res, 25:167-175.
14. Yang W, Tam J, Miller DA, Zhou J, McConville JT, Johnston KP et al. (2008). High bioavailability from nebulized itraconazole nanoparticle dispersions with biocompatible stabilizers. Int J Pharm, 361:177-188.
15. Tam JM, Engstrom JD, Ferrer D, Williams RO 3rd, Johnston KP. (2010). Templated open flocs of anisotropic particles for pulmonary delivery with pressurized metered dose inhalers. J Pharm Sci, 99:3150-3165.
16. Rey L. (1999). Freeze-drying/lyophilization of pharmaceutical and biological products. New York: Informa Healthcare.
17. Adams G. (2007). The principles of freeze-drying cryopreservation and freeze-drying protocols. Day JG and Stacey GN, Totowa, New Jersey: Humana Press. 368: 15-38.
18. Mockus L, LeBlond D, Basu PK, Shah RB, Khan MA. (2011). A QbD case study: Bayesian prediction of lyophilization cycle parameters. AAPS PharmSciTech, 12:442-448.
19. Anchordoquy TJ, Koe GS. (2000). Physical stability of nonviral plasmid-based therapeutics. J Pharm Sci, 89:289-296. (Pubitemid 30152430)
20. Barresi AA, Ghio S, Fissore D, Pisano R. (2009). Freeze drying of pharmaceutical excipients close to collapse temperature: influence of the process conditions on process time and product quality. Drying Technol 27: 805-816.
21. Meryman HT. (1959). Sublimation Freeze-Drying without Vacuum. Science, 130:628-629.
22. Claussen IC, Ustad TS, Strommen I, Walde PM. (2007). Atmospheric freeze drying-a review. Drying Technol 25: 957-967.
23. Mumenthaler M, Leuenberger H. (1991). Atmospheric sprayfreeze drying: a suitable alternative in freeze-drying technology. Int J Pharmaceut 72: 97-110.
24. Men'shutina NV, Korneeva AE, Leuenberger H. (2005). Modeling of atmospheric freeze drying in a spouted bed. Theoret Foundations Chem Engg 39:594-598. (Pubitemid 41817925)
25. Rogers TL, Nelsen AC, Hu J, Brown JN, Sarkari M, Young TJ et al. (2002). A novel particle engineering technology to enhance dissolution of poorly water soluble drugs: spray-freezing into liquid. Eur J Pharm Biopharm, 54:271-280. (Pubitemid 35341826)
26. Rogers TL, Nelsen AC, Sarkari M, Young TJ, Johnston KP, Williams RO 3rd. (2003). Enhanced aqueous dissolution of a poorly water soluble drug by novel particle engineering technology: spray-freezing into liquid with atmospheric freeze-drying. Pharm Res, 20:485-493. (Pubitemid 36292193)
27. Six K, Verreck G, Peeters J, Binnemans K, Berghmans H, Augustijns P, Kinget R, Van den Mooter G. (2001). Investigation of thermal properties of glassy itraconazole: identification of a monotropic mesophase. Thermochimica Acta 376:175-181. (Pubitemid 32803453)
28. Bisoyi HK, Kumar S. (2010). Discotic nematic liquid crystals: science and technology. Chem Soc Rev, 39:264-285.
29. Matsumoto T, Zografi G. (1999). Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization. Pharm Res, 16:1722-1728. (Pubitemid 29530405)
30. Joly C, Le Cerf D, Langevin D, Muller G. (1999). Residual solvent effect on the permeation properties of fluorinated polyimide films. Separation and Purification Technology 16:47-54. (Pubitemid 29432891)
31. Dwivedi AM. (2002). Residual solvent analysis in pharmaceuticals. Pharmaceutical Technol, 42-46. (Pubitemid 35396815)
32. Izutsu K, Fujii K, Katori C, Yomota C, Kawanishi T, Yoshihashi Y et al. (2010). Effects of solute miscibility on the micro-and macroscopic structural integrity of freeze-dried solids. J Pharm Sci, 99:4710-4719.
33. Chatterjee K, Shalaev EY, Suryanarayanan R. (2005). Partially crystalline systems in lyophilization: II. Withstanding collapse at high primary drying temperatures and impact on protein activity recovery. J Pharm Sci, 94:809-820. (Pubitemid 40577313)
34. Patel SM, Doen T, Pikal MJ. (2010). Determination of end point of primary drying in freeze-drying process control. AAPS PharmSciTech, 11:73-84.
35. Overcashier DE, Patapoff TW, Hsu CC. (1999). Lyophilization of protein formulations in vials: investigation of the relationship between resistance to vapor flow during primary drying and smallscale product collapse. J Pharm Sci, 88:688-695. (Pubitemid 29325995)
36. Konstantinidis AK, Kuu W, Otten L, Nail SL, Sever RR. (2011). Controlled nucleation in freeze-drying: effects on pore size in the dried product layer, mass transfer resistance, and primary drying rate. J Pharm Sci, 100:3453-3470.
37. Searles JA, Carpenter JF, Randolph TW. (2001). Annealing to optimize the primary drying rate, reduce freezing-induced drying rate heterogeneity, and determine T(g)' in pharmaceutical lyophilization. J Pharm Sci, 90:872-887. (Pubitemid 32645945)
38. Parker A, Rigby-Singleton S, Perkins M, Bates D, Le Roux D, Roberts CJ et al. (2010). Determination of the influence of primary drying rates on the microscale structural attributes and physicochemical properties of protein containing lyophilized products. J Pharm Sci, 99:4616-4629.
39. Hickey AJ, Mansour HM, Telko MJ, Xu Z, Smyth HD, Mulder T et al. (2007). Physical characterization of component particles included in dry powder inhalers. II. Dynamic characteristics. J Pharm Sci, 96:1302-1319. (Pubitemid 46804583)
40. Emery E, Oliver J, Pugsley T, Sharma J, Zhou J. (2009). Flowability of moist pharmaceutical powders. Powder Technology 189:409-415.
41. Mahajan AN, Pancholi SS. (2010). Formulation and evaluation of timed delayed capsule device for chrnotherapeutic delivery of terbutaline sulphate ARS Pharmaceutica 50:215-223.
42. Kumar V, Kothari SH, Banker GS. (2001). Compression, compaction, and disintegration properties of low crystallinity celluloses produced using different agitation rates during their regeneration from phosphoric acid solutions. AAPS PharmSciTech, 2:E7.article 7
43. Lee YS, Poynter R, Podczeck F, Newton JM. (2000). Development of a dual approach to assess powder flow from avalanching behavior. AAPS PharmSciTech, 1:E21.
44. Yang RY, Yu AB, McElroy L, Bao J. (2008). Numerical simulation of particle dynamics in different flow regimes in a rotating drum. Powder Technology 188:170-177.
45. Pingali KC, Hammond SV, Muzzio FJ, Shinbrot T. (2009). Use of a static eliminator to improve powder flow. Int J Pharm, 369:2-4.
46. Zhu K, Tan RB, Chen F, Ong KH, Heng PW. (2007). Influence of particle wall adhesion on particle electrification in mixers. Int J Pharm, 328:22-34. (Pubitemid 44834453)
47. Pu Y, Mazumder M, Cooney C. (2009). Effects of electrostatic charging on pharmaceutical powder blending homogeneity. J Pharm Sci, 98:2412-2421.
48. Eilbeck J, Rowley G, Carter PA, Fletcher EJ. (2000). Effect of contamination of pharmaceutical equipment on powder triboelectrification. Int J Pharm, 195:7-11. (Pubitemid 30089482)
49. Pingali KC, Shinbrot T, et al. (2009). An observed correlation between flow and electrical properties of pharmaceutical blends. Powder Technology 192:157-165.
50. Karner S, Anne Urbanetz N. (2011). The impact of electrostatic charge in pharmaceutical powders with specific focus on inhalation-powders. J Aerosol Sci 42:428-445.
51. Murtomaa M, Harjunen P, Mellin V, Lehto VP, Laine E. (2002). Effect of amorphicity on the triboelectrification of lactos powder. Journal of Electrostatics 56:103-110. (Pubitemid 34718713)
52. Engstrom JD, Tam JM, Miller MA, Williams RO 3rd, Johnston KP. (2009). Templated open flocs of nanorods for enhanced pulmonary delivery with pressurized metered dose inhalers. Pharm Res, 26:101-117.
53. Watts AB, Peters JI, Talbert RL, O'Donnell KP, Coalson JJ, Williams RO 3rd. (2011). Preclinical evaluation of tacrolimus colloidal dispersion for inhalation. Eur J Pharm Biopharm, 77:207-215.
54. Bennett FS, Carter PA, Rowley G, Dandiker Y. (1999). Modification of electrostatic charge on inhaled carrier lactose particles by addition of fine particles. Drug Dev Ind Pharm, 25:99-103. (Pubitemid 29071492)
55. Ramirez-Dorronsoro JC, Jacko RB, Kildsig DO. (2006). Chargeability measurements of selected pharmaceutical dry powders to assess their electrostatic charge control capabilities. AAPS PharmSciTech, 7:103.
56. Murtomaa M, Mellin V, Harjunen P, Lankinen T, Laine E, Lehto VP. (2004). Effect of particle morphology on the triboelectrification in dry powder inhalers. Int J Pharm, 282:107-114. (Pubitemid 39178488)